Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
Joshi M, Cook J, McCullough K, Nanaa A, Gangat N, Foran JM, Murthy HS, Kharfan-Dabaja MA, Sproat L, Palmer J, Pardanani A, Tefferi A, Begna K, Elliot M, Al-Kali A, Patnaik M, Shah MV, Hogan WJ, Litzow MR, Alkhateeb HB.
Joshi M, et al. Among authors: sproat l.
Blood Cancer J. 2021 Mar 4;11(3):49. doi: 10.1038/s41408-021-00437-z.
Blood Cancer J. 2021.
PMID: 33664234
Free PMC article.
No abstract available.